HemiPhon Competitors

Founded in 2004, SomnoMed® is an Australian Stock Exchange listed medical device company operating in 28 countries. With headquarters in Sydney, Australia and offices in Europe and the United States, SomnoMed® focuses on developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). More than 625,000 patients around the world with mild and moderate OSA have been successfully treated with our oral appliances. SomnoMed® leads the world in the development of OSA devices with each appliance custom made using state-of-the-art technology delivering precision, comfort, and first-time fit solutions. SomnoMed®’s continuous improvement has ensured oral sleep medicine devices have greater efficacy and are more comfortable than ever. Our devices are 510(k) cleared by the FDA (Food and Drug Administration), TGA (Therapeutic Goods Administration) listed and manufactured in accordance with ISO 13485 quality standards. At SomnoMed®, we are committed to providing comfortable and effective OSA treatment that is effective and clinically proven to treat Obstructive Sleep Apnea (OSA). Our passion is to help patients regain their lives again by having a comfortable night sleep.

ProSomnus® is the pioneer and global leader in Smart Sleep Medicine™, delivering precision, non-CPAP Oral Appliance Therapy (OAT) for Obstructive Sleep Apnea (OSA), with integrated multi-night physiologic monitoring enabled by its RPMO2 platform. A serious medical disease affecting over 1 billion people worldwide, OSA is linked to life-threatening comorbidities including heart failure, stroke, and type 2 diabetes. By integrating precision-engineered intraoral medical devices with advanced Remote Patient Monitoring (RPM) and data-driven diagnostics, ProSomnus is redefining the standard of care. Our platform is designed to provide continuous, nightly clinical insights that ensure superior adherence and validated patient outcomes. Non-invasive and patient-preferred, ProSomnus devices have demonstrated exceptional efficacy and safety across a rigorous and growing body of clinical evidence. ProSomnus precision devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, and TRICARE, representing over 200 million covered lives globally. To learn more or find a provider near you, visit www.ProSomnus.com.

Sleep apnea, meet your match. At cpap.com, we demystify sleep apnea and guide you back into the vibrant world of good sleep. As your CPAP-positive partner, we offer expert guidance, top-rated products, and personalized solutions. Family-owned since 1999, we've helped 2 million+ people breathe easier. Let's tackle sleep apnea together and rediscover the power of vibrant, restful nights.